UBS Group’s Cingulate Inc Warrants CINGW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17 Sell
580
-913
-61% -$59 ﹤0.01% 10301
2025
Q4
$82 Sell
1,493
-1,407
-49% -$66 ﹤0.01% 10214
2025
Q3
$157 Buy
+2,900
New +$209 ﹤0.01% 9859
2025
Q2
Sell
-450
Closed -$23 10306
2025
Q1
$23 Buy
+450
New +$23 ﹤0.01% 10076
2024
Q4
Sell
-12,297
Closed -$848 9971
2024
Q3
$848 Sell
12,297
-4,738
-28% -$233 ﹤0.01% 8801
2024
Q2
$187 Buy
17,035
+16,949
+19,708% +$292 ﹤0.01% 9086
2024
Q1
$1 Sell
86
-47,429
-100% -$930 ﹤0.01% 9203
2023
Q4
$1.43K Buy
47,515
+33,272
+234% +$2.21K ﹤0.01% 8308
2023
Q3
$2.35K Buy
+14,243
New +$2.01K ﹤0.01% 7719
2023
Q2
Sell
-1,006
Closed -$151 8993
2023
Q1
$151 Buy
1,006
+923
+1,112% +$215 ﹤0.01% 9175
2022
Q4
$17 Sell
83
-4,015
-98% -$978 ﹤0.01% 10561
2022
Q3
$1K Buy
4,098
+1,900
+86% +$519 ﹤0.01% 9935
2022
Q2
$1K Buy
+2,198
New +$616 ﹤0.01% 9831

Other funds holding CINGW

UBS Group's CINGW Position: Q1 2026 in Review

UBS Group reduced its Cingulate Inc Warrants (CINGW) stake by 61% in Q1 2026, selling an estimated $59 and leaving 580 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #10301.

UBS Group first reported a position in CINGW in Q2 2022 and has held it in 13 quarters since. The position peaked at $2.35K in Q3 2023. 4 funds tracked by Wall St. Rank hold CINGW as of Q1 2026.

  • UBS Group held 580 shares of Cingulate Inc Warrants worth $17 as of Q1 2026.
  • UBS Group sold 913 Cingulate Inc Warrants shares in Q1 2026, an estimated $59.
  • Cingulate Inc Warrants made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10301 holding.
  • UBS Group first reported a position in Cingulate Inc Warrants in Q2 2022 and has held it in 13 quarters since.
  • UBS Group's Cingulate Inc Warrants position peaked at $2.35K in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Cingulate Inc Warrants as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.